CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment
Cardiovascular diseases (CVDs) remain a significant global health challenge, with many current treatments addressing symptoms rather than the genetic roots of these conditions. The advent of CRISPR-Cas9 technology has revolutionized genome editing, offering a transformative approach to targeting dis...
Saved in:
| Main Authors: | Klaudia Bonowicz, Dominika Jerka, Klaudia Piekarska, Janet Olagbaju, Laura Stapleton, Munirat Shobowale, Andrzej Bartosiński, Magdalena Łapot, Yidong Bai, Maciej Gagat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/2/131 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in CRISPR/Cas systems for disease treatment
by: Yangsong Xu, et al.
Published: (2025-06-01) -
The CRISPR/Cas system: Gene Editing by bacterial defense
by: Amira H. El-Ashry
Published: (2023-09-01) -
Post-genomic era of CRISPR/Cas technology in ornamental plants: advantages, limitations, and prospects
by: Ambreena Din, et al.
Published: (2025-01-01) -
Nanotechnology-Based Delivery of CRISPR/Cas9 for Cancer Treatment: A Comprehensive Review
by: Mohd Ahmar Rauf, et al.
Published: (2025-07-01) -
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications
by: Xinmei Liu, et al.
Published: (2025-04-01)